Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 8,686 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Diabetes, Diabetic Foot Ulcer, Non-healing Wound
Interventions: ExpressGraft-C9T1 Skin Tissue; Biological
Lead sponsor: Stratatech, a Mallinckrodt Company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Rotator Cuff Tears, Full-thickness Rotator Cuff Tears
Interventions: nanofiber scaffold; Device
Lead sponsor: Atreon Orthopedics; Industry
Eligibility: 55 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: Fishers, Indiana • Saint Clair Shores, Michigan • Cincinnati, Ohio + 1 more

Conditions: Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
Interventions: Migraine diary and Questionnaires; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Anterior Cruciate Ligament Tear, Meniscal Tear, Cartilage Injury, Bone Bruising
Interventions: Not listed
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: Not listed
Enrollment: 1,646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2025
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Hemophilia A
Interventions: PEGylated Recombinant Factor VIII, ITI; Biological
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: Up to 5 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 20
States / cities: Phoenix, Arizona • Cupertino, California • Oakland, California + 17 more

Conditions: Infertility
Interventions: HSG with acorn-tipped cannula, HSG with cervical vacuum cup, HSG with balloon catheter; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer, Esophageal Cancer, Bladder Cancer, Ovarian Cancer, Abdominal Surgery Complications
Interventions: Multidisciplinary Prehabilitation Program; Behavioral
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Tooth Fractures, Tooth Injuries, Tooth Diseases
Interventions: Allograft, Membrane, Alloplast, Membrane, Xenograft, Membrane, Membrane; Biological
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Skin Ulcer, Pressure Ulcer (PU), Pressure Ulcer of Skin, Pressure Sore, Chronic Ulcer, Pressure Wound
Interventions: Activate™ Matrix + SOC, AmnioDefend™ FT Matrix + SOC, Palisade™ DM Matrix + SOC, Sentry™ SL Matrix + SOC, Shelter™ DM Matrix + SOC; Other
Lead sponsor: Sequence LifeScience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: North Royalton, Ohio

Conditions: Bipolar Depression
Interventions: Deep TMS Treatment, Sham Treatment; Device
Lead sponsor: Brainsway; Industry
Eligibility: 22 Years to 68 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 9
States / cities: Juno Beach, Florida • Palm Beach, Florida • Royal Palm Beach, Florida + 6 more

Conditions: Hyperkalemia
Interventions: Zirconium silicate (acute phase), Zirconium silicate (subacute phase), Placebo (acute phase), Placebo ( subacute phase); Drug
Lead sponsor: ZS Pharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 754 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 42
States / cities: Anniston, Alabama • Huntsville, Alabama • Glendale, Arizona + 37 more

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 200,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Interstitial Lung Disease
Interventions: Pulmonary rehabilitation; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 19 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 5
States / cities: Concord, California • Daly City, California • New Haven, Connecticut + 2 more

Conditions: Tricuspid Regurgitation, Tricuspid Valve Disease
Interventions: TricValve® Transcatheter Bicaval Valve System; Device
Lead sponsor: P+F Products + Features USA Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 36
States / cities: Phoenix, Arizona • Tucson, Arizona • San Diego, California + 31 more

Conditions: Intracranial Venous Pressures
Interventions: Venogram; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Gastrointestinal Disease
Interventions: Probability ramp control, Monitoring; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Urinary Tract Infections, Prostatitis, Interstitial Cystitis
Interventions: Guidance 4.0 PCR test, Urine Culture; Diagnostic Test
Lead sponsor: Pathnostics; Industry
Eligibility: 18 Years and older
Enrollment: 2,511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Lung Cancer
Interventions: FDG; Radiation
Lead sponsor: American College of Radiology Imaging Network; Network
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alzheimer's Disease
Interventions: Placebo, octagam 10%; Drug · Biological
Lead sponsor: Octapharma; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Hoboken, New Jersey

Conditions: Arthroplasty, Replacement, Knee, Total Knee Replacement
Interventions: X3 Polyethylene, N2Vac Polyethylene; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 85 Years
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2023
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Atrial Fibrillation
Interventions: Flecainide, Sotalol; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 100 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 4
States / cities: Chicago, Illinois • Oak Lawn, Illinois

Conditions: Diabetic Neuropathy, Painful
Interventions: Spinal Cord Stimulator (SCS); Device
Lead sponsor: Nevro Corp; Industry
Eligibility: 18 Years and older
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 8
States / cities: Anchorage, Alaska • Ann Arbor, Michigan • West Bloomfield, Michigan + 5 more

Conditions: Systemic Lupus Erythematosus
Interventions: Benlysta, Standard of Care (SoC) Therapy; Biological · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 3,138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 102
States / cities: Birmingham, Alabama • Glendale, Arizona • Goodyear, Arizona + 85 more

Conditions: Parkinson's Disease (PD), Healthy Control Subjects
Interventions: [18F]AV-133; Drug
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years

Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Prospective Registry of Anterior Cruciate Ligament Reconstructions

A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

Comparison of Three Cannulas for Hysterosalpingography

Prehabilitation in High-risk Oncologic Surgery

Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials

Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia

Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Prospective Measurement of Normal Venous Sinus Pressures

Probability Ramp Control of Propofol for EGD

Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

X-3 Polyethylene Survival Outcomes Study

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

PDN Post Market, Multicenter, Prospective, Global Clinical Study

Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.